No FDAer For Commissioner, Interim or Otherwise, Rep. Stupak Urges Obama
Executive Summary
The pharmaceutical industry has an unusual new ally in its effort to achieve some of its goals during the presidential transition: Rep. Bart Stupak, D-Mich
You may also be interested in...
Woodcock Doesn't Want To Be Commissioner – But Has Some Ideas
CDER director believes some management improvements could be made in the executive suite, but she does not aspire to run FDA.
PDUFA Needs Mid-Cycle Correction System As Part Of Reauthorization, Industry Says
Industry wants to place benchmarks in PDUFA that would allow for changes mid-stream, instead of waiting until the end of each five-year cycle.
PDUFA Needs Mid-Cycle Correction System As Part Of Reauthorization, Industry Says
Industry wants to place benchmarks in PDUFA that would allow for changes mid-stream, instead of waiting until the end of each five-year cycle.